Sulphinpyrazone inhibits development of atherosclerosis in rabbits.
The influence of sulphinpyrazone (SP) on the development of atherosclerosis in rabbits was examined. SP administered orally at a dose of 100 mg daily inhibited the formation of atherosclerotic plaques in arteries. At the same time SP suppressed platelet aggregability to collagen.